US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist
  • 57.310
  • -0.320-0.56%
Close Oct 1 16:00 ET
  • 57.310
  • 0.0000.00%
Post 16:01 ET
143.67BMarket Cap30.63P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sanofi Q2 2024 Earnings Date

Currency：EURJul 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
10.38B
11.38B
+1.00B
Beat Est.
+4.13%
+6.53%
+9.67%
EPS
0.56
0.44
-0.11
Miss Est.
-3.73%
-21.96%
-20.48%
Analyst Rating
Buy

Sep 30, 2024

Sanofi Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Jan 30, 20252024/Q4-- / 11.884B--
Oct 25, 20242024/Q3-- / 12.798B--
Jul 25, 20242024/Q210.745B / 10.377B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--
DatePeriodRevenue/EstimateEarnings Call
Jan 30, 20252024/Q4-- / 11.884B--
Oct 25, 20242024/Q3-- / 12.798B--
Jul 25, 20242024/Q210.745B / 10.377B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--

Unlock Free Earnings Estimates

Sanofi Earnings Reports

  • 6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

    Jul 25 11:48 ET

  • 6-K: 2024 Half-Year Financial Report

    Jul 25 10:29 ET

  • Sanofi | 6-K: Colletion of Recent Announcements

    May 2 15:56 ET

  • Sanofi | 6-K: Sanofi Q1 Robust 7% Sales Growth Driven by Launches, Underpins Full-Year Guidance

    Apr 25 10:55 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Infectious Disease
    Infectious Disease
    Intraday0.00%